Increasing funding for research activities is expected to drive India In-Vitro Diagnostic Reagents Market in the forecast period, 2024-2028.
According to TechSci Research report, “India In-Vitro Diagnostics Reagents Market -By Region, Competition Forecast and Opportunities, 2018-2028F”, India In-Vitro diagnostic reagents market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the growing advancement in protein-engineering technologies along with growing development in diagnostic techniques. Similarly, growing investment in the research and development sector along with multiple collaborations with academic institutes to maximize their gains, is further expected to increase the demand for the In-Vitro Diagnostic Reagents market in the forecast period. Additionally, the development of new diagnostics tests and growing awareness about new tests with affordable costs is expected to drive the market during the forecast period. Similarly, the growing geriatric population along with increase in disposable income across the region is anticipated to boost the growth of the in-vitro diagnostic reagents market during the forecast period.
However, strict regulations and policies related to the approval of diagnostic regents can hamper the growth of the India In-Vitro Diagnostic Reagent Market. Similarly, high prices of the reagents along with the risk of using chemical reagents, lack of skilled workers for using the reagents, and lack of reimbursement scenario for IVD test are the main factors that will hamper the India In-Vitro Diagnostic Reagents Market in the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "India In-Vitro Diagnostic Reagents Market"
The India In-Vitro Diagnostic Reagents Market is segmented by type, by application, by end user and by region.
Based on Application, the India In-Vitro Diagnostic Reagents Market can be segmented into Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology Analysers, Urinalysis, and Others. The Immunoassay segment is expected to dominate the market for the forecast period because of the increasing usage of immunoassays in POC & infectious diseases testing, and the growing development of novel tests. Similarly, increasing number of government initiatives taken to fight chronic diseases like influenza outbreaks, and the rising the number of cardiovascular diseases and diabetes, are expected to propel the market growth during the forecast period.
Based on Type, the India In-Vitro Diagnostic Reagents Market can be further segmented into Chemical, Bio-Chemical, and Immunochemical. The Immunochemical segment is predicted to dominate the market in 2023 and maintain its dominance throughout the forecast period. However, increasing approval of therapeutic peptides along with increasing demand for therapeutic proteins and medicines, combined with their subsequent increase in approvals is expected to enhance the demand for In vitro diagnostics reagents market during the forecast period.
Major operating companies operating in India In-Vitro Diagnostic Reagents Market are:
- DiaSys Diagnostics India Pvt Ltd
- Transasia Bio-Medicals Ltd.
- Oscar Medicare Pvt. Ltd.
- CPC Diagnostics (P) Ltd.
- Agappe Diagnostics Ltd
- BioSystems Diagnostics Pvt. Ltd
- Tulip Diagnostics (P) Ltd
PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit, a lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive high-throughput detection of RNA sequences. Similarly, in 2022, the Indian government announced a complete financial cost of USD 665.5 million for the period FY 2021-22 to FY 2025-26 under the Strengthening of Pharmaceutical Industry (SPI) Scheme. Abbott Laboratories, Sysmex Corporation, Thermo Fisher Scientific Inc. and Biomerieux are other top four players in the India IVD market.
Customers can also request for 10% free customization on this report.
“India is expected to register the highest growth in the India In-Vitro Diagnostic Reagents Market due to the rapid urbanization along with growing investments by healthcare providers towards infrastructure improvement across the region. Similarly, growing demand for managing the burden of infectious diseases, and increasing accessibility to healthcare services and advanced products is further expected to support the market growth. Additionally, increasing income levels of the middle-class population and increasing the number of hospitals, and clinics, is anticipated to growth of the market. Similarly, growing demand for personalized medicine for the treatment of chronic diseases along with demand for point of care testing are expected to propel the market growth till 2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“India In-Vitro Diagnostic Reagents Market -Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Chemical, Bio-Chemical, Immunochemical), By Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology Analysers, Urinalysis, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, Others), and By Region”, has evaluated the future growth potential of India In-Vitro Diagnostic Reagents Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India In-Vitro Diagnostic Reagents Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
Factors such as increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, increasing adoption of fully-automated instruments and automation in laboratories, and increasing adoption of point-of-care testing are driving the market growth.The In Vitro Diagnostics Market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%.The oncology segment is expected to grow at the highest CAGR in the in vitro diagnostics marketThe IVD market, by application is segmented into infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, nephrology, and other applications (including genetic disease screening and human leukocyte antigen typing).
The increasing number of cancer cases across the globe, growing demand for personalized medicine treatment, the increasing utility of biomarkers, and availability of funding for cancer research are some of the major factors propelling the growth of this application segment.Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703 Point-of-care testing segment will continue to grow at higher rate till 2023.On the basis of end users, the in vitro diagnostics market is segmented into hospitals, laboratories, poit-of-care testing, patient self-testing, academic institutes, and other end users.
The hospitals segment held the largest share of this market in 2017, while point-of-care testing segment is expected to register highest growth during the forecast period.Regional Analysis:-The in vitro diagnostics market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
In 2017, North America dominates the market; and Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to factors such as government efforts to increase awareness about the early detection of diseases and regular health check-ups; continuously rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China; and strengthening research base for diagnostic procedures across India, China, and Japan.Read More: - https://www.marketsandmarkets.com/PressReleases/ivd-in-vitro-diagnostics.aspTop Key players:-The top five players in this market hold a share of ~55–60% in 2017.
Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) are the leading players in this market.About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
In vitro diagnostics are tests that can detect diseases, conditions, or infections.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.In Vitro Diagnostic (IVD) tests are a subset of medical devices.
In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-in-vitro-diagnostic-s-2019-2024-708According to this study, over the next five years the In Vitro Diagnostic (IVD) Products market will register a 6.8% CAGR in terms of revenue, the global market size will reach US$ 91480 million by 2024, from US$ 65820 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in In Vitro Diagnostic (IVD) Products business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostic (IVD) Products market by product type, application, key manufacturers and key regions and countries.This study considers the In Vitro Diagnostic (IVD) Products value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Immuno DiagnosticsChemistry DiagnosticsMolecular DiagnosticsPOCTOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.HospitalsLaboratoryOtherThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.RocheAbbottDanaherSiemens HealthineersThermo Fisher ScientificSysmexBiomerieuxOrtho Clinical DiagnosticsBecton DickinsonBio-Rad LaboratoriesHologicJohnson and JohnsonQiagenMyriad GeneticsWondfoKHBDAAN GeneLeadman BiochemistryMindrayBioSinoIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global In Vitro Diagnostic (IVD) Products consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of In Vitro Diagnostic (IVD) Products market by identifying its various subsegments.Focuses on the key global In Vitro Diagnostic (IVD) Products manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the In Vitro Diagnostic (IVD) Products with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of In Vitro Diagnostic (IVD) Products submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-in-vitro-diagnostic-s-2019-2024-708Table of content2019–2024 Global In Vitro Diagnostic (IVD) Products Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global In Vitro Diagnostic (IVD) Products Consumption 2014–20242.1.2 In Vitro Diagnostic (IVD) Products Consumption CAGR by Region2.2 In Vitro Diagnostic (IVD) Products Segment by Type2.2.1 Immuno Diagnostics2.2.2 Chemistry Diagnostics2.2.3 Molecular Diagnostics2.2.4 POCT2.2.5 Other2.3 In Vitro Diagnostic (IVD) Products Consumption by Type2.3.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Type (2014–2019)2.3.2 Global In Vitro Diagnostic (IVD) Products Revenue and Market Share by Type (2014–2019)2.3.3 Global In Vitro Diagnostic (IVD) Products Sale Price by Type (2014–2019)2.4 In Vitro Diagnostic (IVD) Products Segment by Application2.4.1 Hospitals2.4.2 Laboratory2.4.3 Other2.5 In Vitro Diagnostic (IVD) Products Consumption by Application2.5.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Application (2014–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
